methyldopa has been researched along with isradipine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (58.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Amir, M; Bar-On, D; Cristal, N; Loidl, A | 1 |
| Arulkumaran, S; Ingemarsson, I; Montan, S; Ratnam, SS; Wide-Swensson, D | 1 |
| Cristal, N; Yodfat, Y | 1 |
| Amir, M; Bar-On, D | 1 |
| Anandakumar, C; Arulkumaran, S; Ingemarsson, I; Montan, S; Ratnam, S | 1 |
| Amir, M; Bar-On, D; Cristal, N; Yodfat, Y | 1 |
| Arulkumaran, S; Biswas, A; Koh, SC; Malcus, P; Ratnam, SS; SvenMontan, S; Yin, KH | 1 |
1 review(s) available for methyldopa and isradipine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 trial(s) available for methyldopa and isradipine
| Article | Year |
|---|---|
Does the combination of ACE inhibitor and calcium antagonist control hypertension and improve quality of life? The LOMIR-MCT-IL study experience.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Captopril; Double-Blind Method; Drug Therapy, Combination; Humans; Hypertension; Isradipine; Male; Methyldopa; Middle Aged; Quality of Life | 1994 |
Effect of methyldopa and isradipine on fetal heart rate pattern assessed by computerized cardiotocography in human pregnancy.
Topics: Adolescent; Adult; Cardiotocography; Female; Heart Rate, Fetal; Humans; Isradipine; Methyldopa; Pre-Eclampsia; Pregnancy; Prospective Studies; Signal Processing, Computer-Assisted | 1993 |
A multicenter, double-blind, randomized, placebo-controlled study of isradipine and methyldopa as monotherapy or in combination with captopril in the treatment of hypertension. The LOMIR-MCT-IH Research Group.
Topics: Adult; Captopril; Double-Blind Method; Drug Therapy, Combination; Humans; Hypertension; Isradipine; Male; Methyldopa; Middle Aged; Treatment Outcome | 1993 |
Reexamining the quality of life of hypertensive patients. A new self-structured measure.
Topics: Adult; Analysis of Variance; Factor Analysis, Statistical; Humans; Hypertension; Isradipine; Male; Methyldopa; Middle Aged; Quality of Life; Reproducibility of Results; Self-Assessment; Surveys and Questionnaires | 1993 |
Randomised controlled trial of methyldopa and isradipine in preeclampsia--effects on uteroplacental and fetal hemodynamics.
Topics: Antihypertensive Agents; Blood Pressure; Female; Gestational Age; Heart Rate; Heart Rate, Fetal; Humans; Isradipine; Methyldopa; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Prospective Studies; Pulsatile Flow | 1996 |
Quality of life in normotensives compared to hypertensive men treated with isradipine or methyldopa as monotherapy or in combination with captopril: the LOMIR-MCT-IL study.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Case-Control Studies; Double-Blind Method; Drug Therapy, Combination; Humans; Hypertension; Isradipine; Male; Methyldopa; Middle Aged; Quality of Life; Treatment Outcome | 1996 |
Preeclampsia: haemostatic status and the short-term effects of methyldopa and isradipine therapy.
Topics: Antihypertensive Agents; Female; Hemostasis; Humans; Isradipine; Methyldopa; Pre-Eclampsia; Pregnancy; Time Factors; Treatment Outcome | 1998 |
4 other study(ies) available for methyldopa and isradipine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |